MRSA in the community.
Chapman
Ann L N
AL
Greig
Julia M
JM
Innes
John A
JA
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000235:genetics; D017714:Community-Acquired Infections / Q000382:microbiology; D004768:Enterotoxins / Q000235:genetics; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D012307:Risk Factors; D012772:Shock, Septic / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000235:genetics; D018089:Superantigens / Q000235:genetics; D014640:Vancomycin / Q000627:therapeutic use; D047090:beta-Lactams / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D004768:Enterotoxins; D018089:Superantigens; D047090:beta-Lactams; C030107:enterotoxin F, Staphylococcal; D014640:Vancomycin